The United States spends roughly $14,885 per person on healthcare each year, more than double the average of $5,967 across wealthy nations. That gap isn’t explained by any single factor. It’s the result of higher prices at every level of the system: drugs cost more, doctors earn more, hospitals charge more, and a massive billing apparatus sits between patients and care, consuming resources that other countries simply don’t spend. Despite all of this, Americans live shorter lives and have higher rates of preventable death than people in peer countries.
The Scale of the Spending Gap
Healthcare consumes about 17.2% of the entire U.S. economy, compared to 9.3% on average across OECD nations. That share is projected to keep climbing, reaching an estimated 18.6% by 2026. Per capita spending is expected to grow from $16,570 in 2024 to $24,200 by 2033.
These numbers dwarf what other wealthy countries pay for universal systems that cover everyone. And the spending doesn’t translate into better health. Life expectancy in the U.S. is 78.4 years, nearly three years below the OECD average. Preventable mortality runs at 217 per 100,000 people, compared to 145 in peer nations. Treatable mortality, meaning deaths that timely healthcare could have prevented, is also significantly higher.
Drug Prices Dwarf the Rest of the World
Prescription drugs are one of the most visible drivers of the cost gap. Brand-name drug prices in the U.S. run about 422% of what other high-income countries pay for the same medications. Even after accounting for the rebates that drug companies pay back to insurers and pharmacy benefit managers, prices are still 308% higher than the international average.
The reason is structural. Most other wealthy nations negotiate drug prices at a national level, setting caps on what manufacturers can charge. France and Japan consistently have the lowest prices. The U.S. has historically allowed manufacturers to set their own prices for most drugs, with negotiations happening piecemeal between drugmakers and individual insurers. The result is that Americans pay several times more for the same pill sitting on a pharmacy shelf in London or Tokyo.
Administrative Costs and Billing Complexity
The U.S. healthcare system runs on a uniquely complicated billing infrastructure. Administrative costs, including planning, regulating, and managing health systems, account for about 8% of total healthcare spending. In other high-income countries, that figure ranges from 1% to 3%.
Private insurers are a major part of the problem. The largest for-profit insurers spend roughly 18% of their revenue on overhead, which includes billing-related functions, claims processing, marketing, executive compensation, and profit. Every doctor’s office, hospital, and clinic needs staff dedicated to navigating different insurance plans, filing claims, handling denials, and chasing reimbursements. This creates an enormous administrative layer that doesn’t exist in countries with simpler payment systems. A hospital in Canada submits claims to one payer. A hospital in the U.S. might deal with dozens of insurers, each with different rules, prior authorization requirements, and reimbursement rates.
Higher Pay for Doctors and Specialists
American physicians earn substantially more than their peers in other wealthy countries. Doctors in the top 1% of earners in the U.S. make roughly $1 million individually, compared to about $500,000 in Canada and less than $400,000 in Sweden or the Netherlands. At the 98th percentile, U.S. physicians earn over $500,000 while their counterparts elsewhere earn around $200,000.
Some of this reflects the broader income distribution in the U.S., where high earners across many professions make more than their international peers. But it also reflects the cost of becoming a doctor in America. Medical school debt averages well over $200,000, and training takes longer than in many other countries. Higher compensation partially offsets those costs, but it also feeds directly into the price of care. When your orthopedic surgeon earns twice what a comparable surgeon earns in Germany, that cost shows up in your hospital bill.
Hospital Consolidation Reduces Competition
Over the past two decades, waves of hospital mergers have concentrated market power in fewer hands. When hospitals merge and face less competition, they charge more. The Federal Trade Commission has found that merged hospitals charge 40 to 50 percent higher prices than they would have without consolidation.
This plays out in predictable ways. In regions where one or two hospital systems dominate, insurers have little leverage to negotiate lower rates. The hospital system can essentially name its price, and insurers pass those costs along through higher premiums. Patients in these markets often have no meaningful alternative, especially for specialized care. The mergers are typically pitched as improving efficiency and quality, but the evidence consistently shows prices go up while quality stays flat or declines.
Fee-for-Service Rewards Volume Over Value
The dominant payment model in U.S. healthcare pays providers for each service they deliver: every office visit, every scan, every blood draw. This fee-for-service structure creates a financial incentive to do more, not necessarily to do what’s most effective. Total spending equals price times quantity, and this model pushes both higher.
Defensive medicine amplifies the effect. Doctors order tests and procedures partly out of genuine clinical concern but also to protect themselves from malpractice lawsuits. This pattern of overtesting is estimated to cost about $46 billion annually. The U.S. has the second-highest number of MRI units per capita among wealthy nations, and there’s no evidence that more machines lead to better outcomes. Avoidable hospital admissions in the U.S. run at 733 per 100,000 people, well above the OECD average of 473, suggesting that many patients end up in expensive hospital settings when less costly care would have been appropriate.
Chronic Disease Adds to the Bill
The U.S. population carries a heavier burden of chronic illness than most peer nations, which compounds all of the pricing problems above. Self-reported obesity prevalence is 35% in the U.S., nearly double the OECD average of 19%. Obesity drives higher rates of diabetes, heart disease, joint problems, and dozens of other conditions that require ongoing, expensive treatment.
This isn’t just a lifestyle issue. It reflects gaps in preventive care, food systems shaped by agricultural subsidies, and the reality that millions of Americans delay or skip care because of cost, allowing manageable conditions to become emergencies. When someone without insurance avoids a $200 doctor’s visit and later shows up in the ER with a $50,000 complication, the system absorbs that cost and spreads it to everyone else through higher prices and premiums.
Why It All Adds Up
No single villain explains why the U.S. spends nearly twice what comparable nations spend on healthcare. It’s the compounding effect of higher prices at every point in the system: drugs priced several times higher than anywhere else, a billing apparatus that consumes 8 cents of every healthcare dollar, physician salaries that dwarf international norms, consolidated hospital markets that eliminate competitive pressure, and a payment model that rewards doing more rather than doing better. Each factor reinforces the others. High administrative costs make it harder to track whether spending is producing results. Lack of competition removes the pressure to lower prices. Fee-for-service incentives encourage more utilization of already-overpriced services.
The result is a system where spending $14,885 per person still produces worse outcomes than countries spending less than half that amount. Americans don’t use dramatically more healthcare services than people in other wealthy nations. They just pay dramatically more for each one.